Home | Ferrer

News

Ferrer acquires worldwide rights to ASN90, an O-GlcNAcase inhibitor to treat Progressive Supranuclear Palsy (PSP)

News

We achieve Great Place To Work certification in 5 countries

News

More than 500 people from Ferrer participate in positive impact activities in nine countries on the Days for Good

#section-two

We are Ferrer

We want to make a positive impact in society

/en/we-are-ferrer/ferrer-for-good

#section-three

Great People

We promote a people-centred culture

/en/great-people

#section-four

Liveable Planet

We promote environmental preservation

/en/liveable-planet

#section-five

Social Justice

We support people in vulnerable situations

/en/social-justice

#section-six

Our activities

This allows us to commit to initiatives that make a positive impact in society

/en/our-activities/pharmaceuticals

#section-seven

Would you like to ask us a question? Contact us.

For queries, to request medical information, become a partner, request an interview, report an adverse reaction or lodge a quality complaint, please leave us a message.